RxDoctor Payments Data

Jeanine Ishmael

Family · Palm City, FLNPI 1609549013

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,218 and has fallen 98.1% since, to $23 in 2024.

$1,585in general payments, 2019–2025

Across 91 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$314
  • Biohaven Pharmaceutical Holding Company Ltd.$164
  • Novartis$146
  • Acadia Pharmaceuticals Inc$114
  • Teva Pharmaceuticals USA, Inc.$69
  • Sanofi$68
  • plus $711 from 22 others

What the payments were for

  • Food & beverage$1,585100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,585 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Other family in Palm City

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →